论文部分内容阅读
目的分析遵义市艾滋病抗病毒治疗死亡病例的流行病学特征,为选择最佳抗病毒治疗时机提供科学依据。方法回顾分析遵义市2006-2013年接受抗病毒治疗后31例死亡病例流行病学资料,使用SPSS17.0软件进行相关分析。结果遵义市2006-2013年累计抗病毒治疗712例,其中男508例,女204例;累计死亡31例,男性22例(4.33%),女性9例(4.41%),男女病死率差异无统计学意义(P=0.877);已婚或同居者病死率为6.23%,离婚或分居者病死率为3.85%,丧偶患者病死率为6.52%,未婚与不详者病死率为0,病死率与患者婚姻状况有关(P=0.018);31例死亡患者中,CD4细胞≤200个/mm326例(83.87%),>200个/mm35例(16.13%);治疗前3个月患者有艾滋病相关症状者病死率为10.71%,无症状者病死率为2.60%(14/539),不详者病死率为6.06%,病死率差异与患者有无艾滋病相关症状相关(P=0.0001);3TC+AZT+NVP治疗方案的病死率(4.49%)高于3TC+AZT+EFV(1.36%),7种治疗方案的病死率差异有统计学意义(P=0.011)。结论治疗者病死率与患者婚姻状况、CD4细胞水平和治疗前是否有机会性感染密切相关,亦与治疗方案有关,及早抗病毒治疗和使用毒副作用小的药物能有效减少病死率。
Objective To analyze the epidemiological characteristics of death from AIDS virus in Zunyi and provide scientific basis for choosing the best antiviral therapy opportunity. Methods The epidemiological data of 31 deaths from 2006 to 2013 in Zunyi City were retrospectively analyzed and analyzed by SPSS17.0 software. Results In 2006-2013, Zunyi City, a total of 712 cases of antiviral therapy, including 508 males and 204 females; total of 31 deaths, 22 males (4.33%) and 9 females (4.41%), the difference was not statistically significant (P = 0.877). The case fatality rate of married or cohabitant was 6.23%, the case fatality rate of divorced or separated was 3.85%, the case fatality rate was 6.52%, the case fatality rate of unmarried and unknown was 0, Marital status (P = 0.018). Among the 31 deaths, CD4 counts ≤200 / mm326 (83.87%) and> 200 / mm35 cases (16.13%). Patients with AIDS-related symptoms The case fatality rate was 10.71%, asymptomatic mortality rate was 2.60% (14/539), and the unknown case fatality rate was 6.06%. The difference in case fatality rate was related to AIDS-related symptoms (P = 0.0001); 3TC + AZT + NVP The case-fatality rate (4.49%) was higher than that of 3TC + AZT + EFV (1.36%). There was a statistically significant difference in mortality among the 7 treatment options (P = 0.011). Conclusion The mortality of patients is closely related to their marital status, CD4 cell level and the possibility of opportunistic infections before treatment. It is also related to the treatment plan. Early anti-viral treatment and the use of drugs with small side effects can effectively reduce the case fatality rate.